Clinical Trials List
2012-03-31 - 2013-12-01
Phase III
Study ended5
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wei-Ting Chang Division of Infectious Disease
- 湯宏仁 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 王瑞興 Division of Infectious Disease
- Po-Chang Lin Division of Infectious Disease
- 周家卉 Division of Infectious Disease
- 林伯昌 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Jann-Tay Wang Division of Infectious Disease
- SUNG-CHING PAN Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
765 participants
